Units comprised of stock, convertible preferreds, seven-year warrants
By Devika Patel
Knoxville, Tenn., June 15 – CareDx, Inc. arranged a private placement of units to raise about $8 million on June 15, according to an 8-K filed Wednesday with the Securities and Exchange Commission.
The company will sell units of one common share, five 0% series A mandatorily convertible preferred shares and three warrants at $23.94 per unit.
Each preferred initially converts to common stock at $3.99 per common share.
The warrants are each exercisable at $4.98 for seven years. The strike price is a 1.01% premium to the June 14 closing share price of $4.93. The conversion price is a 19.07% discount to that price.
Proceeds will be used for working capital and general corporate purposes.
The Brisbane, Calif., company has developed a blood-based test used to monitor heart transplant recipients for acute cellular rejection.
| Issuer: | CareDx, Inc.
|
| Issue: | Units of one common share, five series A mandatorily convertible preferred shares and three warrants
|
| Amount: | $8 million (approximate)
|
| Price: | $23.94
|
| Dividends: | 0%
|
| Conversion price: | $3.99
|
| Warrants: | Three warrants per unit
|
| Warrant expiration: | Seven years
|
| Warrant strike price: | $4.98
|
| Pricing date: | June 15
|
| Stock symbol: | Nasdaq: CDNA
|
| Stock price: | $4.93 at close June 14
|
| Market capitalization: | $70.01 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
